Adults 21 to 30, any sex, with Alcohol Drinking or Alcohol Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Self-Reported EmotionPrimary· during the laboratory session, up to 9 hours
Positive and negative emotion will be assessed during the laboratory beverage-administration session via self-report on the "8-item Mood Measure." This measure yields two subscales (positive emotion; negative emotion) each ranges from 1 to 6. For positive mood, higher value represents increased alcohol reward. For negative mood, lower value represents increased alcohol reward.
Positive Emotion
Group
Value
95% CI
Alcohol Administration
3.49
± 1.085
Control Beverage Administration
2.98
± 1.101
Negative Emotion
Group
Value
95% CI
Alcohol Administration
0.32
± 0.447
Control Beverage Administration
0.673
± 0.750
Self-Reported Social ReinforcementPrimary· during the laboratory session, up to 9 hours
Social reinforcement will be assessed using an index of perceived social closeness as well as a modified version of the Perceived Group Reinforcement Scale. The score of the scale ranges from 1 to 9. Higher score indicates increased alcohol reward.
Group
Value
95% CI
Alcohol Administration
7.471
± 1.129
Control Beverage Administration
7.180
± 1.155
Sponsor's own description
In this study, the investigators examine whether emotional and social reward from alcohol varies depending on the social context of consumption.
Publications & conference data
6 peer-reviewed publications reference this trial (live from Europe PMC):
NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N
· NA
· recruiting
NCT06815237 — Effects of Ketone Supplement and Alcohol on Brain Metabolism
· Phase 2, PHASE3
· recruiting
NCT05363878 — Development of a Culturally Grounded, Trauma-Informed Alcohol Intervention With a Reserve-Dwelling First Nation Group
· NA
· recruiting
NCT06309134 — The Healthy Families Bright Futures Program
· NA
· recruiting
Other University of Illinois at Urbana-Champaign trials
Trials by the same sponsor.
NCT07477067 — Exercise and Protein Efficiency in T2D
· NA
· recruiting
NCT07367854 — Diet Synergy in Muscle Protein Synthesis
· NA
· not yet recruiting
NCT07323862 — Assessment of a Method to Improve Cochlear Implant Users' Speech Perception in Noisy Environments While Maintaining Thei
· NA
· not yet recruiting
NCT07020741 — Stable Isotopes- Adults With Obesity
· NA
· recruiting
NCT07167680 — Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Illinois at Urbana-Champaign
Last refreshed: 31 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03449095.